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1. Introduction 
Puromycin inhibits protein synthesis by substitu- 
ting for an amino-acyl tRNA on ribosomes, causing 
release of growing polypeptide chains [ 1, 21. It has 
been suggested that these released peptides accumulate 
within the cell, causing secondary effects on RNA 
synthesis, [3] carbohydrate metabolism [4] and 
respiration [5]. However, early studies with 
reticulocytes favoured the alternative idea that 
proteolytic enzymes might degrade most of the 
polypeptides released by puromycin [6, 71. More 
recent studies have shown that in E. coli puromycyl 
peptides are rapidly degraded [8], possibly after 
their transient accumulation i to intracellular 
granules [9] . This communication provides evidence 
for a mechanism in both reticulocytes and hepatoma 
cells which very rapidly degrades puromycyl peptides. 
This degradative ability is completely lost in 
cell-free systems, implying that it may require some 
structure normally removed from these preparations. 
2. Materials and methods 
Bat hepatoma cells (HTC; source Dr. G. M. 
Tomklns) were grown in suspension culture in Swims 
S77 medium containing 10% calf serum [lo] . 
Ammo acid incorporation into protein at 37°C was 
measured using radioactive leucine at concentra- 
tions shown in the figure legends. Replicate 1 ml 
a&rots containing 3.5-4.0 X lo5 cells were 
removed and the cells spun down, washed in saline 
and lysed in 0.5 ml 0.5% w/v Na lauryl sulphate 
North-Holland Publishing Company - Amsterdam 
followed by addition of 1 ml 1 N NaOH and 
incubation for 20 min at 37°C. 1.5 ml 25% w/v 
trichloroacetic acid was added, and the precipitates 
collected onto glass flbre filters for scintillation 
counting. 
The HTC Sl 0 was prepared from 5 X 1 O* cells 
which were washed, and then homogenised in twice 
their packed volume of buffer (10 mM KC1 , 1.5 mM 
(CHsCOO)sMg, 20 mM Tris; pH 7.5). l/l0 volume 
of 10 X concentrated solution A (Solution A - 
125 mM KCl, 4 mM (CHsCOO)sMg, 6 mM 
mercaptoethanol, 25mM Tris; pH 7.5) was added 
and the homogenate centrifuged for 10 min at 
10 000 g (4OC). The lipid-containing layer was 
discarded and the remainder passed through 
Sephadex G25 in solution A. Incubations were as 
given by Balkow and Korner [ 141, but with 125 mM 
KC1 and 4 mM (CHsCOO)aMg, in a volume of 
1 ml. Additions of radioactivity were as in the figure 
legends. Aliquots of 30-50 ~1 were dispensed into 
0.5 ml 0.3 N NaOH, incubated at 37°C for 20 min 
and precipitated with 3 ml 10% w/v Ccl sCOOH. 
Rabbit reticulocytes were prepared as described 
[l l] . Incubations were with 0.25 ml of packed cells 
diluted to 1 ml in standard medium [121. Aliquots of 
50 fl were precipitated with 3 ml 0.5 M perchloric 
acid, dissolved in 1 ml of 1 N NaOH, incubated at 
37°C for 20 min, and then reprecipitated with 1 ml 
2 M CClsCOOH. Reticulocyte lysates prepared by the 
method of Lamfrom and Knopf [ 131, were incubated 
according to Balkow and Korner [ 141 with 25 llM 
haem and 1 @i/ml [’ 4 C] leucine. Incubation volumes 
were of 1 ml, and aliquots of 50 /.d were treated 
as for the HTC S IO. 
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3. Results and discussion 
HTC cells incorporated [14C]Ieucine into protein 
linearly for 30 min or more. However, if 0.2-l mM 
puromycin is added after 5 mm there is an immediate 
loss of 14-2076 of the CC1 s COOH precipitable 
radioactivity, which is virtually complete within one 
minute (fig. 1). The most likely explanation for this 
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and this is shown to be the case in fig. 1 b. Fig. 2b 
further confirms that the difference between the two 
cell types may be only in permeability to the inhibitor. 
Reticulocytes were incubated with 0.05 mM puromycin 
(inhibiting amino acid incorporation by about 
50%). After 5 min 0.1 mM cycloheximide was added 
to inhibit protein synthesis completely 
(cycloheximide alone gives no loss of CC1 sCOOH 
(b) 
PUROMYCIN 
V 
08 ’ ’ ’ ’ I ’ ’ ’ OQ ’ ’ ’ ’ ’ ’ 
4 8 12 16 4 8 12 
T I M,E (min 1 
Fig. 1. Effect of puromycin on the incorporation of radioactive leucine into protein by intact HTC cells. (a) HTC cells 
incubated with 0.5 Ki/kl [ 14C] leucine (50 @G/ml; 342 mCi/mmol) (o-o) 1 mM puromycin dihydrochloride (Serva 
Feinbiochemica) ad&d after 5 mins. (Similar results were obtained with 0.2 mM puromycin). ( M) 1 mM puromycin and 
1 mM leucine (unlabelled ad&d at 5 mins (b) Incubation with 0.5 &i/ml [‘HI leucine. (1 Ci/ml; 50 Ci/mmol): (w) 
0.1 mM puromycin added; ( o---o) Control - no additions. 
is a very rapid degradation of some of the acid 
precipitable material, presumably peptides released 
by puromycin. A similar experiment using 
reticulocytes hows an inhibition of incorporation of 
[r4C] leucine after puromycin addition, but only a 
small oss of CC1 sCOOH precipitable counts (fig. 2a). 
This difference may result from a lower permeability 
of reticulocytes to puromycin, giving a lower 
intracellular concentration of inhibitor than in HTC 
cells. This would allow amino acid incorporation to 
continue at a reduced rate and to balance the loss of 
radioactivity due to degradation of puromycyl 
peptides. If this is so, then reducing the amount of 
puromycin added to HTC cells should give a result 
similar to that obtained with reticulocytes in fig. 2a 
precipitable counts). There was an immediate loss 
of radioactivity from the acid precipitable fraction 
which amounted to some 33% of the total counts 
incorporated at 5 min, indicating that reticulocytes 
are just as efficient as HTC cells in removing puromycyl 
peptides. 
That it is the puromycyl peptides which are 
degraded was confirmed by the use of [” H] puromycin. 
When reticulocytes were incubated with [3 H] puro- 
mycin (diluted with cold puromycin to give a final 
concentration of 0.05 mM) for 15 rnln, and then 
cycloheximide added, there was an immediate loss 
of CC 1 s COOH precipitable radioactivity (fig. 2~). 
Similar results were obtained with HTC cells 
(not shown). However, in neither case are all the acid 
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Fig, 2. Effect of puromycin on [ %I] leucine incorporation by intact rabbit reticulocytes and degradation of [aH] puromycyl 
peptides. (a) Incubations with 1 pCi/ml [ r4Cj leucine. (o-o) Control reticulocytes incubated with no further additions. 
(o-o) 0.2 mM puromycin added at 3 min; (X----X) 0.2 mM puromycin and 5 mM unlabelled leucine added at 3 min. 
(b) Incubations with 1 /Ki/ml [r4C] leucine. (O-O) Control reticulocytes. (o-o) Reticulocytes incubated in the presence of 
0.05 mM puromycin. 0.1 mM cycloheximide added after 5 min. (c) (o-o) Time course of incorporation of [aH] puromycin 
dihydrochloride (0.4 mCi/ml; 3.7 Ci/mmol, Radiochemical Centre, Amersham) into intact rabbit reticulocytes. Incubation was 
with 5 rCi/ml [eH] puromycin made up to a final conen. of 0.05 mM with non-radioactive puromycin. 0.1 mM cycloheximide 
was added at 5 min. 
precipitable counts lost, suggesting that some. 
puromycyl peptides (perhaps those above a certain 
length) oan fold into a conformation which is 
resistant to proteolysis). 
There have been reports that cell-free systems 
optimised for protein synthesis are unable to degrade 
proteins which normally have a short half life in in- 
tact cells [ 151. To see whether this is true also of 
puromycyl peptides, we repeated our experiments in 
lysates of HTC cells and reticulocytes. No 
CC1 3COOH precipitable radioactivity was lost on 
addition of puromycin to an HTC SlO (fig. 3a) or a 
reticulocyte lysate (unpublished results). Moreover, 
incorporation of [3 H] puromycin, or of 
[r4C] leucine plus 0.05 n&l puromycin, followed by 
addition of 0.1 n&l cycloheximide gave no loss of 
CC1 3COOH precipitable counts (fig. 3b and 
unpublished results). Therefore it has been 
concluded that there is no degradation of puromycyl 
peptides in either of these two systems. 
It has been suggested [6] that in reticulocytes only 
internally initiated peptide chains released by 
puromycin are degraded by proteolytic enzymes, 
while released peptides initiated from the correct 
N-terminus are stable because they have a 
three-dimensional structure resistant to proteolysis. 
This hypothesis was based on experiments in which 
excess cold amino acids were added with puromycin 
(0.2 mM) to reticulocytes previously incubated with 
[r4C] amino acids, so that radioactivity in teleased 
peptides was confined to those already initiated at 
the correct N-terminus. When this procedure was 
adopted under our conditions of incubation in 
reticulocytes there was very little difference in the 
results (fig. 2a). However, with HTC cells there was 
some reduction in the loss of CC13COOH pre- 
cipitable radioactivity following addition of puromycin 
(fig. la). This suggests that while some of the degraded 
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Fig, 3. Effectsf adding puromycin to an HTC SlO and the stability of [ sH] puromycyl peptides in this system, (a) With 
1 &i/ml [ 14C] leucine in the incubation medium: (o--o ) Control - no additions; (M ) 1 mM puromycin ad&d at 3 min. 
(b) 5 @i/ml [3H] puromycin (1.4 MM) added to incubation medium: ( o----o) Control; (- ) 0.1 mM cycloheximide added 
at 3 min. 
peptides may be internally initiated, others do have 
a correct N-terminal sequence. 
The present findings provide strong evidence for 
the existence of a cellular mechanism for the 
degradation of peptides containing puromycin. This 
is indicative of a more general process for eliminating 
proteins which have changes in their tertiary structure 
making them more susceptible to proteolysis. It has 
been shown in both E. coli [6, 191 and in reticulo- 
cytes [ 161 that proteins containing amino acid 
analogues are also selectively broken down. The 
idea that structural changes are recognized is also 
supported by the finding [ 171 that conditions which 
increase susceptibility of proteins to proteolysis in 
E. coli enhance their sensitivity to well-characterised 
endopeptidases in vitro. Natural ‘abnormal’ proteins 
could be those produced by errors in transcription 
or translation, or those which become denatured 
randomly with age. 
Cell-free protein synthesizing systems of both 
reticulocytes and HTC cells are unable to degrade 
puromycyl peptides. During preparation nuclei, 
mitochondria and other organelles, as well as large 
membrane fragments are removed, leaving mainly 
cytosol and the small amount of microsomes present 
in these cells. Measurement of proteolytic activity 
in various sub-cellular fractions in rat liver [ 181 
has indicated that the cytosol has very low activity. 
Perhaps the proteolytic enzymes concerned are in 
the lysosomes or are found associated with large 
membranes fragments. 
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